For media inquires, please email press@juul.com.
March 17, 2023
In a new white paper entitled “The Real-World Impact of ENDS for Adult Smokers: Tobacco Harm Reduction Through Real-World Data and Evidence,” Juul Labs has reviewed and compiled the latest science and evidence demonstrating the positive real-world impact of ENDS products for adult smokers.
March 3, 2023
The return of Altria’s equity stake and termination of underlying agreements affords us full strategic freedom – we are no longer limited by the…
January 2, 2023
This settlement is a continuation of Juul Labs’ progress to resolve issues from the past. We applaud the Attorney General’s plan to deploy resources…
December 12, 2022
This settlement is a continuation of Juul Labs’ progress to resolve issues from the past. We applaud the Attorney General’s plan to deploy resources…
December 6, 2022
As of today, Juul Labs has reached settlements with plaintiffs in the federal multidistrict litigation (MDL) and related “JUUL Labs Product Cases” (JCCP) that…
October 21, 2022
Today, Juul Labs, Inc. (JLI) posted its administrative appeal of the marketing denial order (MDO) issued by the Food and Drug Administration (FDA), which…
October 6, 2022
“We initiated a company-wide reset to combat underage usage of JUUL products and resolve issues from our past. Since that time, use of JUUL…
September 29, 2022
Joe Murillo delivers keynote remarks at the Global Tobacco & Nicotine Forum 2022.
September 6, 2022
This settlement with 34 states and territories is a significant part of our ongoing commitment to resolve issues from the past. The terms of…
July 6, 2022
With the administrative stay from the FDA now in place, we continue to offer our products to adult smokers while we pursue the Agency’s…